Retroviral vector-mediated gene transfer into endothelial cells is relatively inefficient with transduction rates as low as 1-2% in vitro and even lower in vivo. To increase the efficiency of gene transfer into endothelial cells, we used retroviral vectors expressing f-galactosidase and urokinase and measured endothelial cell transduction efficiencies with quantitative assays for /-galactosidase and urokinase protein. We evaluated several techniques reported to improve the efficiency of retroviral transduction in vitro, including 1) extended periods of exposure to vector, 2) repeated exposures to vector, 3) maximization of the ratio of vector particles to endothelial cells by increasing the volume and concentration of vector particles or by decreasing the number of endothelial cells exposed, 4) cocultivation of endothelial cells with vector-producing cells, and 5) variation of the type and concentration of polycation used with the retroviral vector. Only the use of more concentrated (higher titer) vector-containing supernatant and the use of the polycation DEAE-dextran improved the efficiency of gene transfer into endothelial cells in vitro.
T he endothelium has received much attention as a target for gene transfer because of its potential ability to deliver functional gene products in vivo at sites of vascular disease.1-4 The location of endothelial cells (ECs) along the blood vessel lumen may be ideal for the expression of proteins that control focal vascular disease processes, such as thrombosis and intimal proliferation.56 Although both liposome-mediated gene transfer and calcium phosphate transfection of ECs have been reported,78 retroviral vector-mediated gene transfer remains the most versatile and widely used method of gene transfer into ECs. 19 Retroviral vectors possess the advantages of stable integration and resultant long-term expression of transferred genetic material10 as well as a proven safety record in human clinical protocols.1'
Realization of the potential of retroviral vectormediated gene transfer to deliver significant levels of recombinant gene products from the endothelium has been limited by low transduction efficiency (TE). Zwiebel et al'2 reported a TE of 0.5-1%, as determined by neomycin selection of rabbit aortic ECs after a single exposure to a retroviral vector-containing supernatant with a titer of 5 x 105 colony-forming units (CFU)/ml. Wilson et a14 reported variable TE with canine ECs (5-60%), as determined by visual analysis of histochemically stained plates after successive exposures to f8-galactosidase-containing retroviral vector with titers of 0.5-5x 105 CFU/ml. In our laboratory, the efficiency of retroviral vector-mediated gene transfer into bovine and rabbit aortic ECs, sheep venous and arterial ECs, human umbilical vein ECs, and baboon external jugular vein ECs has been between 1% and 15% (Reference 13; and unpublished observations, M. Kahn and D. Dichek) . Production of a purified population of genetically engineered ECs has therefore required the use of vectors containing the selectable neomycin phosphotransferase gene (which occupies precious space within the vector) followed by 2 weeks of antibiotic selection and expansion of the surviving cells in culture.'4 Direct in vivo gene transfer into vascular cells with retroviral vectors has also been attempted with transduction efficiencies even lower than those found in vitro."", 16 For purely in vitro experiments, a delay of 2-3 weeks to obtain a purified population of transduced cells is not clearly problematic. However, for protocols in which either transduced cells are reimplanted in vivo or transduction itself is performed in vivo, low TE is a major obstacle. Antibiotic selection is time consuming and expensive. Prolonged in vitro culture may alter the EC phenotype17"18 and expose the cells to a continual danger of microbial contamination, with consequent failure of a reimplantation protocol. Low efficiency of gene transfer renders an in vivo gene transfer protocol unlikely to produce a biological effect. Therefore, high TE is desirable for ex vivo protocols and essential for in vivo protocols. Despite the importance of increasing the efficiency of retroviral vector-mediated gene transfer into ECs, no study has systematically investigated TE and attempted to optimize it. Although one finds techniques in use that purportedly enhance the rate of transduction, such as repetitive exposure to retroviral vector-containing supernatants,4 optimization of the calculated multiplicity of infection (MOI),'9 and addition of particular concentrations of polycation such as Polybrene or Protamine to vector-containing supernatant,20 there are little or no published data to support these practices. In the present study, we used bovine aortic ECs (BAECs) and vectors encoding both intracellular and secreted gene products to evaluate the role of many of the factors commonly believed to affect TE both in ECs as well as in other cell types. Specifically, we determined 1) the effects of varying either length of exposure or frequency of exposure to retroviral vectors, 2) the importance of the titer of the retroviral vectorcontaining supernatant and the effect of concentrating supernatant by centrifugation to increase titer, 3) the contribution of the type and concentration of polycation used to enhance TE, and 4) the effect on TE of cocultivating BAECs with the cells that produce the retroviral vector. Two optimized transduction schemes are proposed for either 6-hour or 15-minute exposures to retroviral vector-containing supernatants. The former protocol is useful for optimizing in vitro gene transfer; the latter may eventually be useful for in vivo gene transfer protocols, in which time of exposure of cells to the vector must be kept to a minimum.
Materials and Methods Cell Harvest and Culture
BAECs were isolated from a fresh aorta using the method of Jaffe et al. 21 Endothelial cell identity was confirmed using immunoperoxidase staining with antibody to human von Willebrand's factor (Atlantic Antibodies, Scarborough, Me.) and by fluorescent staining for the presence of acetylated low density lipoprotein receptors22 (Biomedical Technologies Inc., Stoughton, Mass.). BAECs were maintained in Dulbecco's modified Eagle's medium (DMEM, Biofluids, Inc., Rockville, Md.) containing 10% heat-inactivated fetal calf serum (Hyclone Laboratories Inc., Logan, Utah) at 37°C and 5% CO2. This medium formulation is hereafter referred to as D-10. Cells were passaged using trypsin-EDTA digestion, and all experiments were performed with cells passaged fewer than 12 times. LTR, and neomycin phosphotransferase is expressed from the simian virus 40 early promoter. Multiple vectors were used to ensure that results were generally applicable and not vector or protein specific. High titer amphotropic retroviral vector-containing supernatant was generated in PA-31726 packaging cells by transinfection, as described previously.'3 We defined titer, as have others,'9 as the number of infectious vector particles per milliliter of supernatant, which was measured by the ability of a sample of the supernatant to transfer antibiotic resistance to NIH 3T3 cells. Titer was measured by plating 2.5 x 104 3T3 cells per 35-mm well 24 hours before exposure to 1.5 ml serially diluted supernatant containing 8 gg/ml Polybrene (Aldrich Chemical Co., Milwaukee, Wis.) for 2 hours. After 24 hours, the medium was changed to D-10 containing 0.8 mg/ml G418 (a neomycin analogue that kills untransduced 3T3 cells in 5-7 days), and resistant colonies were counted 12-14 days later. All viral supernatants were free of helper virus, as assessed by the S+L-assay.27 The titer of supernatant after one freeze-thaw cycle was 5-10 x 1iO for LBgSN and 1-l0x 105 for G1BgSVNa and LUKSN. Supernatant that had been frozen once and thawed for use was used for all experiments, except those in which fresh supernatant was concentrated and used without freezing. We defined MOI as the calculated ratio of the number of infectious vector particles (determined by multiplying titer by supernatant volume) to the total number of target cells at the time of exposure to supernatant: MOI (CFU/cell)=titer of supernatant (CFU/ml)xvolume of supernatant (ml)/target cell number. Target cell number at the time of exposure to the supernatant was determined by trypsinization and counting of cells in wells maintained in parallel to those being transduced.
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Measurement of TE
TE was measured by quantitation of reporter gene protein production. The advantages of measuring TE by protein production as opposed to Southern analysis or polymerase chain reaction for inserted vector DNA are as follows: 1) Recombinant protein production is the most important end point of gene transfer, whereas measurement of DNA gives only an indirect indication of the ultimate success of gene transfer. Because of potential inefficiencies of transcription and translation, quantitation of DNA may not correlate with protein production. 28 2) The linearity and reproducibility of the protein assays permit quantification of TE with reference to a standard curve within the typical range of TE measurements (5-80%) and allow confident discrimination of TEs within this range (e.g., 15% versus 30% transduction).
3) The sensitivity of the protein assays allows the measurement of TE even in the setting of very low levels of gene transfer (<5%). Southern analysis is far less sensitive than the protein assays. Polymerase chain reaction is extremely sensitive but must be very carefully controlled to permit even relative quantification.29 A caveat in this analysis is that a higher TE, as measured by protein production, may be due to either a greater percentage of transduced cells or a higher number of vector copies per cell in the same number of transduced cells. However, these possibilities can be differentiated experimentally (see below).
We used f3-galactosidase and urokinase as reporter to each 35-mm well. Urokinase secretion was calculated with reference to both time of collection and total cellular protein for each well.
By using the measured amount of f3-galactosidase activity or urokinase antigen, TE was calculated as the percentage of transduced (i.e., 83-galactosidase-containing or urokinase-secreting) cells in each sample. To we constructed standard curves of f3-galactosidase activity per transduced cell and urokinase secretion per transduced cell using mixed populations of untransduced cells and transduced G418-selected cells. Briefly, a pure population of transduced cells was created by selection over 14 days in 0.4 mg/ml G418, a concentration that kills 100% of untransduced cells in 7 days. Transduced selected cells and untransduced cells were then counted and plated together in triplicate wells at constant total cell number in proportions of 80%, 40%, 20%, 10%, 5%, 2.5%, 1.25%, and 0% transduced cells.
,8-Galactosidase activity or urokinase antigen secretion was determined for each of the mixtures as described above, and linear regression equations were derived from plots of activity or antigen secretion versus the percentage of transduced cells. The initial equation that was derived for 83-galactosidase-expressing cells and applied for calculation of TE was as follows: transduced cells (%)=(microunits ,3-galactosidase activity per milligram cellular protein) x 1.16+0.84. In later experiments, a second equation was generated in which a new mixture of f-galactosidase-expressing cells and a new enzyme standard were used to express the units of Transduction Protocols Standard transduction conditions. The following protocol, used regularly in our laboratory before the present study, was defined as a standard transduction. BAECs were plated at 5 x 104 cells per well onto 35-mm wells on day 1. On day 2 (20 hours after plating), the medium was replaced with 1.5 ml viral supernatant containing 8 ,ug/ml Polybrene (Aldrich) for 6 hours, after which the medium was replaced with fresh D-10 medium. The medium was again changed on day 4. On day 5 (72 hours after exposure to the supernatant), cells and conditioned medium were collected as described above for measurement of either ,B-galactosidase or urokinase. Standard transduction, as defined in this article, refers specifically to this protocol.
Determination of the effect of the duration of exposure to viral supernatant on TE. To determine if the practice of exposing target cells to supernatant for extended periods of time improves TE in BAECs, we varied the duration of a single supernatant exposure. BAECs were exposed to supernatant for 2, 6, 12, or 24 hours, with other conditions unchanged from those of the standard transduction.
Determination of the effect offrequency of exposure to viral supernatant on TE. To determine if the practice of allow the calculation of percentage of transduced cells, exposing target cells to retroviral vector repetitively improves TE, BAECs were exposed to the supernatant on multiple occasions. As an additional variable, the time intervals between the repeated exposures were also changed. In the first experimental design, BAECs underwent one, two, or three standard transductions separated by time intervals of 24 hours (time between the start of one supernatant exposure and the start of any subsequent exposures). In the second experimental design, BAECs underwent three standard transductions at 48-hour intervals or two standard transductions at 72-hour intervals. In this manner, BAECs were exposed multiple times to new solutions of retroviral vector with 1) adequate time between exposures to regenerate surface receptor proteins potentially necessary for retroviral vector binding and cell entry and 2) minimal chance that, over the course of the experiment, the BAEC cell cycle would precisely coincide with the time interval between supernatant exposures and thereby repetitively expose all cells at the same point in their cell cycle. In all cases, TE was determined by harvesting cells and assaying for recombinant protein expression 72 hours after the final supernatant exposure. Determination of the effect ofMOI on TE by alteration of either 1) supernatant volume, 2) cell number, or 3) supernatant concentration. 1) To alter MOI by varying the volume of supernatant, standard transductions were performed with 0.5, 1, 2, 4, or 6 ml supernatant. The volume range was limited by the need to cover the cells with a minimal amount of medium and by the maximum volume of the wells. 2) To alter MOI by varying the number of target cells, standard transductions were performed with 103, 5 X 103, 104, and 5 x 104 BAECs. 3)
To alter MOI by varying the vector concentration in the supernatant, standard transductions were performed with either thawed viral supernatant or maximally concentrated fresh viral supernatant as well as serial dilutions of both in D-10 medium containing 8 gg/ml Polybrene. To achieve maximal vector concentration, the supernatant was concentrated using a sterile technique by centrifuging 36 ml fresh supernatant at 15,000 rpm in a Beckman SW28 rotor for 2 hours at 4°C with a recovery of 1-3 ml from the bottom of the tube and repetitive trituration around the bottom of the tube. 32 In contrast to experiments done with unconcentrated supernatants, the concentrated supernatants were not frozen but were used immediately both for experiments and for simultaneous titering on 3T3 cells.
Determination of the contributions of the polycations Polybrene and DEAE-dextran to TE. Standard transductions were performed with Polybrene and DEAE-dextran (Pharmacia, Uppsala, Sweden) using concentrations of either of these two polycations varying from 4 to 80 ,ug/ml. In addition, in a separate experiment designed to minimize the time of exposure to the polycations with their associated toxicity, BAECs were incubated in DMEM containing high concentrations (0.1 or 1 mg/ml) of either Polybrene or DEAE-dextran for only 60 seconds before exposure to the supernatant for 6 hours. In a third experimental design based on favorable results obtained with a 60-second DEAE-dextran exposure, BAECs were exposed to DEAE-dextran for 60 seconds and then to the supernatant for periods ranging from 15 to 360 minutes. In all of these experiments, cells sures. TE was measured 72 hours after the end of the supernatant exposure.
Cocultivation of BAECs with viral producer cells. A cocultivation apparatus was used in which BAECs were grown on tissue culture inserts of 25-mm diameter and 0.45-,um pore size (Falcon, Lincoln Park, N.J.) above vector producer cells. This apparatus prevented mixing of the cells but theoretically allowed vector particles (approximately 0.08 ,um in diameter33) to come into contact with the basolateral membrane of plated BAECs through the pores of the tissue culture insert. Unlike the cocultivation applied to transduction of hematopoietic cells in which the target cells are mixed with producer cells that have been lethally irradiated,34 this design was chosen to allow continuous access to freshly produced vector but to prevent the potential mixing of cell types. BAECs (2.5 x 104) were plated onto the tissue culture inserts located in 35-mm wells. Twenty-four hours after plating, this tissue culture insert was transferred to a 35-mm well above a 70% confluent layer of producer cells. Medium was replaced every 24 hours with fresh D-10 containing 4 ,ug/ml Polybrene. TE was determined as described above 72 hours after the termination of exposure to producer cells.
Results
Duration and Frequency of Exposure to Viral Supernatant
In this series of experiments as well as in others described below, we report results from individual experiments in which the same batch of supernatant was used for each experimental group rather than pooled results from several experiments in which different batches of supernatant were used, a practice that would have allowed small differences in the titer of the supernatant used to become an uncontrolled variable. Individual experiments include data points obtained with triplicate wells and were virtually always repeated both with the same vector and with at least one different vector, as detailed below.
A single 2-hour exposure to the LBgSN vector transduced 2-4% of BAECs; under the same conditions, the LUKSN vector transduced 10-25% of the target cells. Increasing the duration of supernatant exposure to 6 hours resulted in a small increase in TE over a 2-hour exposure. However, this difference did not consistently achieve statistical significance. Incubations of 12 or 24 hours did not further improve TE over a 6-hour incubation (Figure 2A and data not shown).
Multiple supernatant exposures were attempted to increase TE on the theoretical basis that 1) a greater total percentage of cells might be exposed to vector during active cell replication and thus be susceptible to retroviral vector-mediated transduction35 and 2) cells might receive multiple copies of vector DNA with consequently increased recombinant protein production if successfully infected by retroviral vectors on multiple occasions. In these experiments, TE after a single 6-hour exposure to supernatant was approximately 6% for LBgSN and 10% for LUKSN. Use of either two or three separate 6-hour exposures at 24-hour intervals failed to improve TE significantly with either of these were washed three times with phosphate-buffered saline (Biofluids) after both polycation and supernatant expo-vectors ( Figure 2B and data not shown). Lengthening of the time interval between exposures from 24 to either Bovine aortic endothelial cells were exposed to LBgSN or LUKSN supernatant with 8 ,g/ml Polybrene (Aldrich Chemical Co., Milwaukee, Wis.) for 2, 6, 12, or 24 hours. Data are mean ±SD of triplicate wells from individual experiments. This experiment was performed twice with each of the vectors; results were similar to those illustrated. Panel B: Bovine aortic endothelial cells were exposed to LBgSNor LUKSN-containing supernatant with 8 pg/ml Polybrene for 6 hours at 24-hour intervals one to three times. Data are mean ±SD oftriplicate wells. As discussed in the text and illustrated herein, interexperimental transduction efficiency (the difference in percent transduction by L UKSN in panels A and B) was sufficiently variable that the data are more clearly presented as individual experiments. This experiment was performed twice with LBgSN and once with LUKSN. 48 or 72 hours, which would be expected to reduce further any synchronization between cell cycle and virion exposure, also failed to augment TE over that obtained with a single 6-hour exposure to aliquots of the same batch of vector-containing supernatant (data not shown).
Variation of Multiplicity of Infection
We investigated the relation between MOI and TE by varying each of the three elements that determine MOI: supernatant volume, target cell number, and vector concentration. In the first set of experiments, MOI was varied over a 12-fold range for LBgSN and LUKSN by increasing the volume of virion-containing supernatant with a constant target cell population ( Table 1 ). In the second set of experiments, MOI for G1BgSVNa and LUKSN was varied over a 50-fold range by reducing the number of BAECs without a change in supernatant volume ( Table 1) . When the lowest MOI was used in each of the experiments, TE was approximately 4% with LBgSN, 20% with G1BgSVNa, and 12-22% with LUKSN. Substantial increases in MOI in each of the two experimental designs and with each of the three vectors revealed no significant increases in TE over these baseline values. Thus, neither an increase in absolute virion number nor a decrease in plated target cell number resulted in higher TE. There was actually a decrease in TE of approximately 50% at target cell plating densities below 5 X 104 cells per 35-mm well.
We next attempted to increase MOI by concentrating the virion-containing supernatant. The ability of the concentration protocol to increase supernatant titer was tested by comparing the titer of aliquots of supernatant, which were either concentrated then titered or titered without prior concentration. A 20-fold concentration of supernatant (by volume) raised titer approximately 1 log (n=2). However, despite the ability of the concentration protocol to increase supernatant titer substantially, use of concentrated supernatant to transduce BAECs resulted in only a marginal increase in TE (20-30% Multiplicity of Infection (cfu/cell) increase over the maximum TE attainable with unconcentrated supernatant) with either LBgSN (n =3) or LUKSN (n =2) ( Figure 3 and data not shown).
To further discern the relation between vector concentration and TE, transductions were performed with serial dilutions of either unconcentrated or concentrated supernatant. A striking relation was found between MOI and TE: after an initial plateau, TE decreased with a linear relation to MOI (Figure 3 and data not shown). Therefore, TE is related to MOI in a linear fashion if one dilutes a given aliquot of supernatant beyond twofold to fourfold. However, if one uses this linear relation to predict the effect of supernatant concentration on TE, the actual TE obtained using concentrated supernatant consistently falls below the predicted value (Figure 3 and data not shown). This observation correlates with the failure of supernatant concentration to increase TE proportionately. Endothelial cells were exposed to supernatant for 6 hours in the presence of the polycations Polybrene (Aldrich Chemical Co., Milwaukee, Wis.) or DEAE-dextran at the indicated concentrations. Data are from a single experiment with each of the vectors. *Cell death of >50%.
Polycation Effect
The enhancement of TE with the polycations Polybrene and DEAE-dextran was first investigated by adding increasing concentrations of polycation to the vector-containing supernatant and incubating the supernatant with the target cells for 6 hours. Omission of polycation resulted in virtually undetectable TE ( Table  2 ). Addition of Polybrene at a concentration of 4 ,ug/ml resulted in TE of approximately 15% for both G1BgSVNa and LUKSN ( Table 2 and data not shown). Increasing the concentration of Polybrene over the range of 4-32 ,ug/ml did not consistently result in significant increases in TE using either of the vectors. Addition of DEAE-dextran at a concentration of 5 ,ug/ml resulted in increased TE over that obtained with any of the concentrations of Polybrene. In the experiment described in Table 2 , TE was 30% for G1BgSVNa and 35% for LUKSN, approximately twice that obtained using the same supernatant with added Polybrene at any concentration. As with Polybrene, increasing DEAE-dextran concentration above 5 ,ug/ml did not result in consistent dose-dependent increases in TE with either vector ( Table 2 and data not shown). Increasing DEAE-dextran above 10 ,ug/ml was limited by associated cellular toxicity. With both vectors, DEAEdextran concentrations of 20, 40, and 80 ug/ml resulted in >50% cell death, as observed directly with phasecontrast microscopy and confirmed by comparison of total cellular protein with that of cells in parallel wells receiving lower concentrations of DEAE-dextran or Polybrene (data not shown). Because of the toxicity of DEAE-dextran, TE could be measured reliably only occasionally at 20 gg/ml DEAE-dextran and never at 40 or 80 ,ug/ml. When either LUKSN or G1BgSVNa was used, TE with 20 ,ug/ml DEAE-dextran (when it could be measured) was not significantly different from that obtained at 10 ,ug/ml ( Table 2 and data not shown, n=3). The entire experiment illustrated in Table 2 was repeated with similar results. This experiment was performed a total of three times with each vector, always with similar results.
To increase TE while minimizing associated cellular toxicity, we attempted brief high-concentration DEAEdextran exposure before the addition of supernatant. A 60-second exposure to DEAE-dextran at a concentration of either 0.1 or 1 mg/ml before supernatant exposure resulted in a TE of 50-90% for both G1BgSVNa and LUKSN compared with 9-17% for standard transductions done in parallel with either of the two vectors (Figure 4 and data not shown, n=6). Thus, brief exposure to high-concentration DEAE-dextran resulted in a 2.5-fold to eightfold increase in TE over that obtained with a standard transduction protocol. Cellular toxicity was 20-30% with both 0.1 and 1 mg/ml DEAE-dextran, as observed directly by phase-contrast microscopy and quantified by comparison of total cellular protein with that of cells grown in parallel wells and transduced using a standard Polybrene transduction (data not shown). In contrast to the results obtained with DEAE-dextran, 60-second exposures to Polybrene at concentrations of 0.1 and 1 mg/ml did not improve TE over that obtained with a standard transduction (data not shown). Given that a 60-second exposure to DEAE-dextran was effective at enhancing TE, the time of subsequent supernatant exposure was varied to determine whether it could also be reduced. Again, with either G1BgSVNa or LUKSN, 6 hours of supernatant exposure resulted in TE of 60-70% ( Figure 5 and data not shown). Decreasing the time of supernatant exposure resulted in a drop in TE. However, with as little as 15 minutes of supernatant exposure after a 60-second exposure to 1 mg/ml DEAE-dextran, TE remained at 15-20%, equivalent to the efficiency of a standard 6-hour Polybrene transduction done in parallel. Cellular toxicity with 1 mg/ml DEAE-dextran was again 20-30%. Higher TE, as Measured by Recombinant Protein Production, Is Due to a Greater Percentage of Transduced Cells Because we used the level of recombinant protein to quantitate TE, it is possible that an increase in reporter gene expression is due to a higher level of expression per cell rather than a greater percentage of transduced cells. To discriminate these two possibilities, two approaches were used. In the first approach, curves of ,B-galactosidase activity and urokinase secretion were constructed (as described in "Materials and Methods" for use in the determination of percentage positive cells) with G418-selected cell populations obtained with three different methods of transduction: 1) a standard (Polybrene) transduction, 2) a 60-second exposure to 1 mg/ml DEAE-dextran followed by 6 hours of supernatant exposure, and 3) a 60-second exposure to 1 mg/ml DEAE-dextran followed by 15 minutes of supernatant exposure. The curves for each group obtained by transduction with the LBgSN vector are shown in Figure 6 . For each group of cells, the normalized activity (in microunits per milligram cellular protein) per transduced cell was virtually identical. Similar standard curves resulted from a repetition of this experiment using the LUKSN vector (data not shown). Therefore, the measured increases in reporter gene expression using the DEAE-dextran transduction protocols result from a higher percentage of transduced cells rather than an increase in reporter gene expression per cell. In a second, confirmatory approach, BAECs were transduced with the G1BgSVNa vector by either the "standard" or "optimized" protocols. Histochemical A rationale for these methods is that retroviral vectormediated gene transfer occurs only in actively replicat-Transduced Cells (%) ing cells35'42; therefore, the longer and more frequently that target cells are exposed to vector, the greater the -O-Polybrene -v-DEAE-Dex -A-DEAE-Dex probability that any given cell will be cycling at the time min) 360 360 15 of exposure. Serial exposures could conceivably result in raph showingcellular expression of ,B-galactothe transfer of more than one vector copy per cell. different methods of transduction. Standard Despite these theoretical arguments, we were unable to alactosidase expression in G418-selected cells improve TB in BABCs with >6 hours of exposure or hree different transduction protocols are shown. sures suggests both that the cell cycle does not signifiopulations were selected in 0.4 mg/ml G418, and cantly limit TE in cultured BAECs (perhaps because at es were generated by mixing transduced selected the plating densities used the cells are continuously ransduced cells, as described in "Materials and replicating) and that repeated transduction of the same titer done on a diluted sample of supernatant to determine the effective vector concentration in more concentrated samples. Although the biological basis of this observation is not addressed in the present study (the disproportionate presence in concentrated supernatant of damaged virions or other inhibitors of transduction could conceivably play a role43), the practical consequence is that the concentration of supernatant raises the titer to a far greater extent than it raises TE. Concentration is therefore not a practical means by which to increase TE of endothelial cells. Given that the majority of BAECs could be exposed to transducing virions at an MOI of up to 100 without being transduced (Table 1) , we reasoned that a more fruitful approach might consist of efforts to improve virion-target cell interaction. More than 20 years ago, polycations were shown to enhance the infection efficiencies of a number of viruses, including the murine leukemia virus, from which retroviral vectors are derived.4445 Certain of these previous experiments44 revealed that the infectivity of murine leukemia virus in 3T3 cells was enhanced 20-fold by DEAE-dextran (at an optimal concentration of 20 ,ug/ml) and 10-fold by Polybrene (at concentrations between 2 and 8 ,ug/ml). The proposed mechanism of action of polycations is the creation of a cell/polycation/virus particle sandwich in which the polycation mediates apposition of the negatively charged cell and viral surface membranes,444647 resulting in a higher effective local concentration of vector particles and in an improvement in the efficiency of uptake of virions. This hypothesis is supported by previous observations47 and by our own data (not shown) demonstrating that the beneficial effects of DEAE-dextran preincubation on TE can be reversed by the addition of a polyanion, such as heparin, to the DEAE-dextran solution. In sum, our results confirm the dependence of TE on the presence of polycations and indicate that DEAE-dextran is the polycation of choice for transduction of BAECs.
To decrease the cellular toxicity associated with prolonged exposure to DEAE-dextran, we used brief exposures to higher DEAE-dextran concentrations. This approach has been reported with transfection of DNA4849 into eukaryotic cells but has not been applied previously to retroviral vector-mediated gene transfer. Our data demonstrate that this technique is effective not only in limiting cellular toxicity but results in reliably high (50-90%) TE. These high TE values are achievable with supernatant of only moderately high titer (105_106 CFU/ ml) and are the highest yet reported in endothelial cells, therefore suggesting that we have developed a protocol for reliable high efficiency gene transfer into endothelial cells in vitro. It is significant that this protocol is successful when using supernatant of a titer that, based on our experience, is easily attainable with most retroviral vectors, for this obviates the need for extensive manipulation of producer cells that may lead to contamination with pathogenic helper virus.5051
Despite the success of the in vitro protocol, there are several issues that will need to be examined as the protocol is extended to optimize direct in vivo endothelial transduction. These issues include reduction of the total duration of the protocol (due to the requirement for short periods of vessel occlusion), probable decreased efficiency of retroviral vector-mediated gene transfer into the normally nondividing ECs of the vessel wall, and utilization of endogenous cellular promoter elements that may be less active (though more stably expressed in vivo) than the viral LTR. 52 We have made some progress toward resolution of the first of these issues by reduction of the total duration of the transduction protocol to under 20 minutes ( Figure 5 ), although this is achieved at a significant cost in TE. It will be of interest to compare this protocol and improvements thereupon to thce e used by ourselves and by others to achieve in vivo gene transfer into the vessel wall.2'3 '16 We anticipate that the conceptual framework provided by the present in vitro study will be useful in the design of protocols to optimize in vivo transduction as well.
